Change Language

Select Language

Press Release:

Global Hormone Replacement Therapy Market to Witness Moderate Growth During 2020-2025, Fostered by Rising Incidences of Hormonal Imbalance Disorders

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global hormone replacement therapy market reached a value of US$ 8.16 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. 

Hormone replacement therapy (HRT) is used for replenishing the hormones that are present in low levels in the human body. This treatment is particularly favourable for patients with growth hormone deficiency, women nearing menopause and elderly people suffering from hypogonadism. HRT is available in several forms such as skin and mouth patches (transdermal), gels, injections and implants. However, HRT may not be suitable for patients who have a history of blood clots, liver disease and untreated high blood pressure. This therapy may also include some adverse effects like bloating, swelling, nausea, leg cramps, headaches, indigestion, increased cholesterol levels and a rise in the number of red blood cells. 

A surge in the incidences of hormone imbalance disorders in the geriatric and neonatal populations is primarily driving the market growth. The rising need for new treatment options with better safety results is further boosting the demand for (HRT) hormone replacement therapy. Additionally, aggressive marketing and direct selling campaigns by the key players along with the development of new gel-based formulations creates an attractive market for these therapies. Moreover, increasing awareness among the consumers and the presence of regularly monitored formulations are some of the other drivers stimulating the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global hormone replacement therapy market, along with forecasts at the global and regional level from 2021-2026. Our report has categorized the market based on product, route of administration and type of disease.

Breakup by Product:

  • Estrogen Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy
  • Others
     

Based on product, estrogen replacement therapy accounts for the majority of the market share. Other types include human growth hormone replacement therapy, testosterone replacement therapy, thyroid replacement therapy and others.

Breakup by Route of Administration:

  • Oral
  • Parenteral
  • Transdermal
     

On the basis of route of administration, the report has segmented the market on the basis of oral, parenteral and transdermal segments.

Breakup by Type of Disease:

  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others
     

On the basis of disease, the report has segmented the market on the basis of menopause, hypothyroidism, male hypogonadism, growth hormone deficiency and others.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America
     

Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the largest market, accounting for the majority of the market share.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Bayer AG,  Eli Lilly & Company, Roche, Hisamitsu Pharmaceutical Co. Inc., Merck, Mylan, Novartis, Novo Nordisk and Pfizer.

This report provides a deep insight into the global hormone replacement therapy market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the hormone replacement therapy market in any manner.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Product, Route of Administration, Type of Disease, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered Abbott Laboratories, Bayer AG,  Eli Lilly & Company, Roche, Hisamitsu Pharmaceutical Co. Inc., Merck, Mylan, Novartis, Novo Nordisk and Pfizer
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Hormone Replacement Therapy Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Price Analysis
    5.5    Market Breakup by Product
    5.6    Market Breakup by Route of Administration
    5.7    Market Breakup by Type of Disease
    5.8    Market Breakup by Region
    5.9    Market Forecast
    5.10    SWOT Analysis
        5.10.1    Overview
        5.10.2    Strengths
        5.10.3    Weaknesses
        5.10.4    Opportunities
        5.10.5    Threats
    5.11    Value Chain Analysis
        5.11.1    Overview
        5.11.2    Research and Development
        5.11.3    Raw Material Procurement
        5.11.4    Manufacturing
        5.11.5    Marketing
        5.11.6    Distribution
        5.11.7    End-Use
    5.12    Porters Five Forces Analysis
        5.12.1    Overview
        5.12.2    Bargaining Power of Buyers
        5.12.3    Bargaining Power of Suppliers
        5.12.4    Degree of Competition
        5.12.5    Threat of New Entrants
        5.12.6    Threat of Substitutes
6   Market Breakup by Product
    6.1    Estrogen Replacement Therapy
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Human Growth Hormone Replacement Therapy
        6.2.1    Market Trends
        6.2.2    Market Forecast
    6.3    Thyroid Replacement Therapy
        6.3.1    Market Trends
        6.3.2    Market Forecast
    6.4    Testosterone Replacement Therapy
        6.4.1    Market Trends
        6.4.2    Market Forecast
    6.5    Others
        6.5.1    Market Trends
        6.5.2    Market Forecast
7   Market Breakup by Route of Administration
    7.1    Oral
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Parenteral
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Transdermal
        7.3.1    Market Trends
        7.3.2    Market Forecast
8   Market Breakup by Type of Disease
    8.1    Menopause
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Hypothyroidism
       8.2.1    Market Trends
       8.2.2    Market Forecast
    8.3    Male Hypogonadism
        8.3.1    Market Trends
        8.3.2    Market Forecast
    8.4    Growth Hormone Deficiency
        8.4.1    Market Trends
        8.4.2    Market Forecast
    8.5    Others
        8.5.1    Market Trends
        8.5.2    Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Europe
       9.2.1    Market Trends
       9.2.2    Market Forecast
    9.3    Asia Pacific
        9.3.1    Market Trends
        9.3.2    Market Forecast
    9.4    Middle East and Africa
        9.4.1    Market Trends
        9.4.2    Market Forecast
    9.5    Latin America
        9.5.1    Market Trends
        9.5.2    Market Forecast
10  Competitive Landscape
    10.1    Market Structure
    10.2    Key Players
    10.3    Profiles of Key Players
       10.3.1 Abbott Laboratories
       10.3.2 Bayer AG
       10.3.3 Eli Lilly & Company
       10.3.4 Roche
       10.3.5 Hisamitsu Pharmaceutical Co. Inc.
       10.3.6 Merck 
       10.3.7 Mylan NV
       10.3.8 Novartis AG
       10.3.9 Novo Nordisk A/S
       10.3.10 Pfizer Inc

List of Figures

Figure 1: Global: Hormone Replacement Therapy Market: Major Drivers and Challenges
Figure 2: Global: Hormone Replacement Therapy Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Hormone Replacement Therapy Market: Breakup by Product (in %), 2020
Figure 4: Global: Hormone Replacement Therapy Market: Breakup by Route of Administration (in %), 2020
Figure 5: Global: Hormone Replacement Therapy Market: Breakup by Type of Disease (in %), 2020
Figure 6: Global: Hormone Replacement Therapy Market: Breakup by Region (in %), 2020
Figure 7: Global: Hormone Replacement Therapy Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 8: Global: Hormone Replacement Therapy Industry: SWOT Analysis
Figure 9: Global: Hormone Replacement Therapy Industry: Value Chain Analysis
Figure 10: Global: Hormone Replacement Therapy Industry: Porter’s Five Forces Analysis
Figure 11: Global: Hormone Replacement Therapy (Estrogen) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Hormone Replacement Therapy (Estrogen) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Hormone Replacement Therapy (Human Growth Hormone) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Hormone Replacement Therapy (Human Growth Hormone) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Hormone Replacement Therapy (Thyroid) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Hormone Replacement Therapy (Thyroid) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Hormone Replacement Therapy (Testosterone) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Hormone Replacement Therapy (Testosterone) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Hormone Replacement Therapy (Other Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Hormone Replacement Therapy (Other Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Hormone Replacement Therapy (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Hormone Replacement Therapy (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Hormone Replacement Therapy (Parenteral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Hormone Replacement Therapy (Parenteral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Hormone Replacement Therapy (Transdermal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Hormone Replacement Therapy (Transdermal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Hormone Replacement Therapy (Menopause) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Hormone Replacement Therapy (Menopause) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Hormone Replacement Therapy (Hypothyroidism) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Hormone Replacement Therapy (Hypothyroidism) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Hormone Replacement Therapy (Male Hypogonadism) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Hormone Replacement Therapy (Male Hypogonadism) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Hormone Replacement Therapy (Growth Hormone Deficiency) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Hormone Replacement Therapy (Growth Hormone Deficiency) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Hormone Replacement Therapy (Other Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Hormone Replacement Therapy (Other Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: North America: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: North America: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Europe: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Europe: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Asia Pacific: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Asia Pacific: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Middle East and Africa: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Middle East and Africa: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Latin America: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Latin America: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

Table 1: Global: Hormone Replacement Therapy Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Hormone Replacement Therapy Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 3: Global: Hormone Replacement Therapy Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 4: Global: Hormone Replacement Therapy Market Forecast: Breakup by Type of Disease (in Million US$), 2021-2026
Table 5: Global: Hormone Replacement Therapy Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Hormone Replacement Therapy Market: Competitive Structure
Table 7: Global: Hormone Replacement Therapy Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Question Answered in this Report

The global hormone replacement therapy market reached a value of US$ 8.16 Billion in 2020.

According to the estimates by IMARC Group, the global hormone replacement therapy market will exhibit moderate growth during the next five years.

The rising prevalence of hormone imbalance disorders, particularly among the geriatric and neonatal populations, is primarily driving the global market for hormone replacement therapy.

The introduction of innovative drug delivery systems, including new gel-based formulations and estrogen patches, represents one of the key trends in the global hormone replacement therapy market.

Sudden outbreak of the COVID-19 pandemic had led to the limited number of hospital visits for mitigating the risk of coronavirus transmission, thereby hampering the demand for elective hormone replacement therapy across the globe.

On the basis of the product, the market has been bifurcated into estrogen replacement therapy, human growth hormone replacement therapy, testosterone replacement therapy, thyroid replacement therapy, and others. Amongst these, estrogen replacement therapy holds the majority of the total market share.

On the basis of the route of administration, the market has been classified into oral, parenteral, and transdermal segments. At present, parenteral route of administration exhibits a clear dominance in the market.

On the basis of type of disease, the market has been categorized into growth hormone deficiency, hypothyroidism, menopause, male hypogonadism, and others. Currently, menopause accounts for the majority of the total market share.

Region-wise, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America dominates the global market.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Tissue Engineering Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Nanoemulsion Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Transfection Reagents and Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Onychomycosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Pet Insurance Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Social Links